Report cover image

AI Tumor Evolution Maps Market Forecasts to 2032 – Global Analysis By Cancer Type (Brain Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer, Hematologic Malignancies, Rare & Pediatric Cancers and Other Cancer Types),

Publisher Stratistics Market Research Consulting
Published Sep 15, 2025
Length 200 Pages
SKU # SMR20398408

Description

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global AI Tumor Evolution Maps Market, By Cancer Type
5.1 Introduction
5.2 Brain Cancer
5.3 Lung Cancer
5.4 Breast Cancer
5.5 Colorectal Cancer
5.6 Prostate Cancer
5.7 Pancreatic Cancer
5.8 Hematologic Malignancies
5.9 Rare & Pediatric Cancers
5.10 Other Cancer Types
6 Global AI Tumor Evolution Maps Market, By Technology
6.1 Introduction
6.2 Imaging-Based Mapping (MRI, CT, PET)
6.3 Genomic and Transcriptomic Mapping
6.4 AI-Powered Predictive Modeling
6.5 Multi-Omics Integration Platforms
6.6 Spatial Transcriptomics
6.7 Digital Twin Modeling
6.8 Federated Learning & Privacy-Preserving AI
7 Global AI Tumor Evolution Maps Market, By Application
7.1 Introduction
7.2 Diagnosis and Early Detection
7.3 Prognosis and Risk Assessment
7.4 Treatment Planning
7.5 Drug Development and Clinical Trials
7.6 Tumor Monitoring and Recurrence Prediction
7.7 Biomarker Discovery
7.8 Patient Stratification for Immunotherapy
8 Global AI Tumor Evolution Maps Market, By End User
8.1 Introduction
8.2 Hospitals and Clinics
8.3 Research Institutes
8.4 Pharmaceutical & Biotechnology Companies
8.5 Academic Institutions
8.6 Diagnostic Laboratories
8.7 AI & Health Tech Startups
9 Global AI Tumor Evolution Maps Market, By Geography
9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.2.3 Mexico
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 Italy
9.3.4 France
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 New Zealand
9.4.6 South Korea
9.4.7 Rest of Asia Pacific
9.5 South America
9.5.1 Argentina
9.5.2 Brazil
9.5.3 Chile
9.5.4 Rest of South America
9.6 Middle East & Africa
9.6.1 Saudi Arabia
9.6.2 UAE
9.6.3 Qatar
9.6.4 South Africa
9.6.5 Rest of Middle East & Africa
10 Key Developments
10.1 Agreements, Partnerships, Collaborations and Joint Ventures
10.2 Acquisitions & Mergers
10.3 New Product Launch
10.4 Expansions
10.5 Other Key Strategies
11 Company Profiling
11.1 Azra AI
11.2 Siemens Healthineers AG
11.3 GE HealthCare
11.4 NVIDIA Corporation
11.5 Median Technologies
11.6 PathAI
11.7 Paige
11.8 AstraZeneca
11.9 CancerIQ
11.10 X-ZELL
11.11 MNM Bioscience
11.12 Biotome
11.13 Immunai
11.14 OncoHost
11.15 Tempus
11.16 1Cell.Ai
List of Tables
Table 1 Global AI Tumor Evolution Maps Market Outlook, By Region (2024-2032) ($MN)
Table 2 Global AI Tumor Evolution Maps Market Outlook, By Cancer Type (2024-2032) ($MN)
Table 3 Global AI Tumor Evolution Maps Market Outlook, By Brain Cancer (2024-2032) ($MN)
Table 4 Global AI Tumor Evolution Maps Market Outlook, By Lung Cancer (2024-2032) ($MN)
Table 5 Global AI Tumor Evolution Maps Market Outlook, By Breast Cancer (2024-2032) ($MN)
Table 6 Global AI Tumor Evolution Maps Market Outlook, By Colorectal Cancer (2024-2032) ($MN)
Table 7 Global AI Tumor Evolution Maps Market Outlook, By Prostate Cancer (2024-2032) ($MN)
Table 8 Global AI Tumor Evolution Maps Market Outlook, By Pancreatic Cancer (2024-2032) ($MN)
Table 9 Global AI Tumor Evolution Maps Market Outlook, By Hematologic Malignancies (2024-2032) ($MN)
Table 10 Global AI Tumor Evolution Maps Market Outlook, By Rare & Pediatric Cancers (2024-2032) ($MN)
Table 11 Global AI Tumor Evolution Maps Market Outlook, By Other Cancer Types (2024-2032) ($MN)
Table 12 Global AI Tumor Evolution Maps Market Outlook, By Technology (2024-2032) ($MN)
Table 13 Global AI Tumor Evolution Maps Market Outlook, By Imaging-Based Mapping (MRI, CT, PET) (2024-2032) ($MN)
Table 14 Global AI Tumor Evolution Maps Market Outlook, By Genomic and Transcriptomic Mapping (2024-2032) ($MN)
Table 15 Global AI Tumor Evolution Maps Market Outlook, By AI-Powered Predictive Modeling (2024-2032) ($MN)
Table 16 Global AI Tumor Evolution Maps Market Outlook, By Multi-Omics Integration Platforms (2024-2032) ($MN)
Table 17 Global AI Tumor Evolution Maps Market Outlook, By Spatial Transcriptomics (2024-2032) ($MN)
Table 18 Global AI Tumor Evolution Maps Market Outlook, By Digital Twin Modeling (2024-2032) ($MN)
Table 19 Global AI Tumor Evolution Maps Market Outlook, By Federated Learning & Privacy-Preserving AI (2024-2032) ($MN)
Table 20 Global AI Tumor Evolution Maps Market Outlook, By Application (2024-2032) ($MN)
Table 21 Global AI Tumor Evolution Maps Market Outlook, By Diagnosis and Early Detection (2024-2032) ($MN)
Table 22 Global AI Tumor Evolution Maps Market Outlook, By Prognosis and Risk Assessment (2024-2032) ($MN)
Table 23 Global AI Tumor Evolution Maps Market Outlook, By Treatment Planning (2024-2032) ($MN)
Table 24 Global AI Tumor Evolution Maps Market Outlook, By Drug Development and Clinical Trials (2024-2032) ($MN)
Table 25 Global AI Tumor Evolution Maps Market Outlook, By Tumor Monitoring and Recurrence Prediction (2024-2032) ($MN)
Table 26 Global AI Tumor Evolution Maps Market Outlook, By Biomarker Discovery (2024-2032) ($MN)
Table 27 Global AI Tumor Evolution Maps Market Outlook, By Patient Stratification for Immunotherapy (2024-2032) ($MN)
Table 28 Global AI Tumor Evolution Maps Market Outlook, By End User (2024-2032) ($MN)
Table 29 Global AI Tumor Evolution Maps Market Outlook, By Hospitals and Clinics (2024-2032) ($MN)
Table 30 Global AI Tumor Evolution Maps Market Outlook, By Research Institutes (2024-2032) ($MN)
Table 31 Global AI Tumor Evolution Maps Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN)
Table 32 Global AI Tumor Evolution Maps Market Outlook, By Academic Institutions (2024-2032) ($MN)
Table 33 Global AI Tumor Evolution Maps Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN)
Table 34 Global AI Tumor Evolution Maps Market Outlook, By AI & Health Tech Startups (2024-2032) ($MN)
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Table of Contents

200 Pages
1 Executive Summary 2 Preface 2.1 Abstract 2.2 Stake Holders 2.3 Research Scope 2.4 Research Methodology 2.4.1 Data Mining 2.4.2 Data Analysis 2.4.3 Data Validation 2.4.4 Research Approach 2.5 Research Sources 2.5.1 Primary Research Sources 2.5.2 Secondary Research Sources 2.5.3 Assumptions 3 Market Trend Analysis 3.1 Introduction 3.2 Drivers 3.3 Restraints 3.4 Opportunities 3.5 Threats 3.6 Technology Analysis 3.7 Application Analysis 3.8 End User Analysis 3.9 Emerging Markets 3.10 Impact of Covid-19 4 Porters Five Force Analysis 4.1 Bargaining power of suppliers 4.2 Bargaining power of buyers 4.3 Threat of substitutes 4.4 Threat of new entrants 4.5 Competitive rivalry 5 Global AI Tumor Evolution Maps Market, By Cancer Type 5.1 Introduction 5.2 Brain Cancer 5.3 Lung Cancer 5.4 Breast Cancer 5.5 Colorectal Cancer 5.6 Prostate Cancer 5.7 Pancreatic Cancer 5.8 Hematologic Malignancies 5.9 Rare & Pediatric Cancers 5.10 Other Cancer Types 6 Global AI Tumor Evolution Maps Market, By Technology 6.1 Introduction 6.2 Imaging-Based Mapping (MRI, CT, PET) 6.3 Genomic and Transcriptomic Mapping 6.4 AI-Powered Predictive Modeling 6.5 Multi-Omics Integration Platforms 6.6 Spatial Transcriptomics 6.7 Digital Twin Modeling 6.8 Federated Learning & Privacy-Preserving AI 7 Global AI Tumor Evolution Maps Market, By Application 7.1 Introduction 7.2 Diagnosis and Early Detection 7.3 Prognosis and Risk Assessment 7.4 Treatment Planning 7.5 Drug Development and Clinical Trials 7.6 Tumor Monitoring and Recurrence Prediction 7.7 Biomarker Discovery 7.8 Patient Stratification for Immunotherapy 8 Global AI Tumor Evolution Maps Market, By End User 8.1 Introduction 8.2 Hospitals and Clinics 8.3 Research Institutes 8.4 Pharmaceutical & Biotechnology Companies 8.5 Academic Institutions 8.6 Diagnostic Laboratories 8.7 AI & Health Tech Startups 9 Global AI Tumor Evolution Maps Market, By Geography 9.1 Introduction 9.2 North America 9.2.1 US 9.2.2 Canada 9.2.3 Mexico 9.3 Europe 9.3.1 Germany 9.3.2 UK 9.3.3 Italy 9.3.4 France 9.3.5 Spain 9.3.6 Rest of Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 New Zealand 9.4.6 South Korea 9.4.7 Rest of Asia Pacific 9.5 South America 9.5.1 Argentina 9.5.2 Brazil 9.5.3 Chile 9.5.4 Rest of South America 9.6 Middle East & Africa 9.6.1 Saudi Arabia 9.6.2 UAE 9.6.3 Qatar 9.6.4 South Africa 9.6.5 Rest of Middle East & Africa 10 Key Developments 10.1 Agreements, Partnerships, Collaborations and Joint Ventures 10.2 Acquisitions & Mergers 10.3 New Product Launch 10.4 Expansions 10.5 Other Key Strategies 11 Company Profiling 11.1 Azra AI 11.2 Siemens Healthineers AG 11.3 GE HealthCare 11.4 NVIDIA Corporation 11.5 Median Technologies 11.6 PathAI 11.7 Paige 11.8 AstraZeneca 11.9 CancerIQ 11.10 X-ZELL 11.11 MNM Bioscience 11.12 Biotome 11.13 Immunai 11.14 OncoHost 11.15 Tempus 11.16 1Cell.Ai List of Tables Table 1 Global AI Tumor Evolution Maps Market Outlook, By Region (2024-2032) ($MN) Table 2 Global AI Tumor Evolution Maps Market Outlook, By Cancer Type (2024-2032) ($MN) Table 3 Global AI Tumor Evolution Maps Market Outlook, By Brain Cancer (2024-2032) ($MN) Table 4 Global AI Tumor Evolution Maps Market Outlook, By Lung Cancer (2024-2032) ($MN) Table 5 Global AI Tumor Evolution Maps Market Outlook, By Breast Cancer (2024-2032) ($MN) Table 6 Global AI Tumor Evolution Maps Market Outlook, By Colorectal Cancer (2024-2032) ($MN) Table 7 Global AI Tumor Evolution Maps Market Outlook, By Prostate Cancer (2024-2032) ($MN) Table 8 Global AI Tumor Evolution Maps Market Outlook, By Pancreatic Cancer (2024-2032) ($MN) Table 9 Global AI Tumor Evolution Maps Market Outlook, By Hematologic Malignancies (2024-2032) ($MN) Table 10 Global AI Tumor Evolution Maps Market Outlook, By Rare & Pediatric Cancers (2024-2032) ($MN) Table 11 Global AI Tumor Evolution Maps Market Outlook, By Other Cancer Types (2024-2032) ($MN) Table 12 Global AI Tumor Evolution Maps Market Outlook, By Technology (2024-2032) ($MN) Table 13 Global AI Tumor Evolution Maps Market Outlook, By Imaging-Based Mapping (MRI, CT, PET) (2024-2032) ($MN) Table 14 Global AI Tumor Evolution Maps Market Outlook, By Genomic and Transcriptomic Mapping (2024-2032) ($MN) Table 15 Global AI Tumor Evolution Maps Market Outlook, By AI-Powered Predictive Modeling (2024-2032) ($MN) Table 16 Global AI Tumor Evolution Maps Market Outlook, By Multi-Omics Integration Platforms (2024-2032) ($MN) Table 17 Global AI Tumor Evolution Maps Market Outlook, By Spatial Transcriptomics (2024-2032) ($MN) Table 18 Global AI Tumor Evolution Maps Market Outlook, By Digital Twin Modeling (2024-2032) ($MN) Table 19 Global AI Tumor Evolution Maps Market Outlook, By Federated Learning & Privacy-Preserving AI (2024-2032) ($MN) Table 20 Global AI Tumor Evolution Maps Market Outlook, By Application (2024-2032) ($MN) Table 21 Global AI Tumor Evolution Maps Market Outlook, By Diagnosis and Early Detection (2024-2032) ($MN) Table 22 Global AI Tumor Evolution Maps Market Outlook, By Prognosis and Risk Assessment (2024-2032) ($MN) Table 23 Global AI Tumor Evolution Maps Market Outlook, By Treatment Planning (2024-2032) ($MN) Table 24 Global AI Tumor Evolution Maps Market Outlook, By Drug Development and Clinical Trials (2024-2032) ($MN) Table 25 Global AI Tumor Evolution Maps Market Outlook, By Tumor Monitoring and Recurrence Prediction (2024-2032) ($MN) Table 26 Global AI Tumor Evolution Maps Market Outlook, By Biomarker Discovery (2024-2032) ($MN) Table 27 Global AI Tumor Evolution Maps Market Outlook, By Patient Stratification for Immunotherapy (2024-2032) ($MN) Table 28 Global AI Tumor Evolution Maps Market Outlook, By End User (2024-2032) ($MN) Table 29 Global AI Tumor Evolution Maps Market Outlook, By Hospitals and Clinics (2024-2032) ($MN) Table 30 Global AI Tumor Evolution Maps Market Outlook, By Research Institutes (2024-2032) ($MN) Table 31 Global AI Tumor Evolution Maps Market Outlook, By Pharmaceutical & Biotechnology Companies (2024-2032) ($MN) Table 32 Global AI Tumor Evolution Maps Market Outlook, By Academic Institutions (2024-2032) ($MN) Table 33 Global AI Tumor Evolution Maps Market Outlook, By Diagnostic Laboratories (2024-2032) ($MN) Table 34 Global AI Tumor Evolution Maps Market Outlook, By AI & Health Tech Startups (2024-2032) ($MN) Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us